If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,424.00    -12.00 (-0.84%)
Bid:
1,432.00
Ask:
1,438.00
Spread: 6.00 (0.419%)
Market Cap: £652.62m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

AGM Statement and First Quarter Update

27 Sep 2022 07:00

RNS Number : 7049A
Cohort PLC
27 September 2022
 

One Waterside Drive

Arlington Business Park

Reading

Berks

RG7 4SW

 

 

 

27 September 2022

 

 

 

 

 

 

COHORT PLC

("Cohort" or "the Group")

 

AGM STATEMENT & FIRST QUARTER UPDATE

 

Maritime Capability Investor Presentation

 

Cohort, the AIM listed technology group, is today holding its Annual General Meeting (AGM) and accordingly issues the following announcement:

 

AGM Statement and first quarter update

 

Cohort's performance last year was in line with our revised expectations at the time of the half year results in December 2021, with robust cash generation, and a record closing order book with strong cover for the current financial year commencing 1 May 2022. The order book not only grew in value, but its longevity continued to increase with orders across the Group stretching out to 2030. 

 

The Group's record order book of £291.0m at 30 April 2022 underpins nearly £128m of the current financial year revenue, representing 78% (2021: 64%) of current consensus forecast for the year. Following order wins since 1 May 2022 of over £70m, including a £34m contract win for SEA (announced 7 September 2022), the order book on 20 September 2022 stood at over £300m with revenue cover of current consensus forecast for the year of 95%.

 

Cohort maintains its sound finances: net funds at 23 September 2022 stood at £7.2m, compared to net funds of £11.0m at 30 April 2022 reflecting the timing of working capital flows. The Group's cash and readily available credit was over £40m at 23 September 2022 providing significant financing headroom beyond our currently anticipated commitments.

 

We have continued to see a higher level of activity from the UK MOD, particularly at MCL which we expect to exceed last year's performance significantly. As we indicated at the time of the Group's preliminary results announcement on 28 July 2022, we are seeing some impact from supply chain delays and price increases, and this has been most noticeable at EID, which has also continued to experience order delays. We now expect EID's performance to be weaker than we saw in 2021/22. 

 

Overall, we continue to expect that our trading performance for 2022/23 will be ahead of that achieved for the year ended 30 April 2022. We also remain optimistic that the Group will make further progress in 2023/24, based on current orders for long-term delivery and on our pipeline of opportunities.

 

Maritime Capability Investor Presentation

 

The Group is hosting an investor presentation highlighting the Group's maritime capability later today, featuring an overview of the global maritime defence marketplace and drivers, and detailing the capabilities and current market focus of Cohort's leading maritime specialist subsidiaries, SEA (Systems Engineering & Assessment Ltd) and ELAC Sonar GmbH. No new material information will be disclosed during the event.

 

A recording of the presentations will be made available on the Company's website (https://www.cohortplc.com/investors/results-reports-presentations) after the event.

 

 

 

ENDS

 

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

Simon Walther, Finance Director

Raquel McGrath, Company Secretary

Investec Bank Plc (NOMAD and Broker)

020 7597 5970

Daniel Adams, Christopher Baird

MHP Communications

020 3128 8276

Reg Hoare, Ollie Hoare, Pete Lambie

cohort@mhpc.com

 

 

NOTES TO EDITORS

 

Cohort plc (www.cohortplc.com) is the parent company of six innovative, agile and responsive businesses based in the UK, Germany and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

Chess offers surveillance, tracking and fire-control systems to the defence and security markets. A majority stake was acquired by Cohort plc in December 2018. www.chess-dynamics.com

 

EID designs and manufactures advanced communications systems for naval and military customers. Cohort acquired a majority stake in June 2016. www.eid.pt

 

ELAC SONAR supplies advanced sonar systems and underwater communications to global customers in the naval marketplace. Acquired by Cohort in December 2020. www.elac-sonar.de 

 

MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services and training support. Acquired by Cohort in August 2006. www.mass.co.uk

 

MCL designs, sources and supports advanced electronic and surveillance technology for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

 

SEA delivers and supports technology-based products for the defence and transport markets alongside specialist research and training services. Acquired by Cohort in October 2007. www.sea.co.uk

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has headquarters in Reading, Berkshire and employs in total around 1,000 core staff there and at its main operating company sites across the UK, Germany and Portugal.

 

 

 

.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMPPUWUBUPPGMQ
Date   Source Headline
20th Sep 202410:48 amRNSDirector/PDMR Shareholding
16th Sep 20245:34 pmRNSHolding(s) in Company
2nd Sep 20245:08 pmRNSTotal Voting Rights
2nd Sep 202411:32 amRNSHolding(s) in Company
27th Aug 20245:54 pmRNSBlock listing six monthly return
21st Aug 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Aug 20243:48 pmRNSDirector/PDMR Shareholding
16th Aug 202412:10 pmRNSHolding(s) in Company
12th Aug 20244:22 pmRNSDirector/PDMR Shareholding
2nd Aug 20242:30 pmRNSDirector/PDMR Shareholding
1st Aug 202411:43 amRNSTotal Voting Rights
29th Jul 20249:45 amRNSDirector/PDMR Shareholding
23rd Jul 20245:04 pmRNSDirector/PDMR Shareholding
17th Jul 20247:01 amRNSContract win
17th Jul 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSContract Award
11th Jul 20247:00 amRNSNotice of Results
1st Jul 20249:33 amRNSTotal Voting Rights
5th Jun 202410:59 amRNSEBT Purchase of Shares
31st May 20243:17 pmRNSTotal Voting Rights
23rd May 20241:30 pmRNSEBT Purchase of Shares
23rd May 20247:00 amRNSFull Year Trading Update
20th May 20244:01 pmRNSEBT Purchase of Shares
14th May 20242:10 pmRNSEBT Purchase of Shares
7th May 20245:24 pmRNSEBT Purchase of Shares
3rd May 202411:44 amRNSDirector/PDMR Shareholding
1st May 20245:17 pmRNSDirector/PDMR Shareholding
1st May 20245:11 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSBlock Listing Application
30th Apr 20247:00 amRNSSite visit to SEA
15th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20242:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSBlock Listing Six Monthly Return
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 20242:06 pmRNSHolding(s) in Company
27th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSContract Win
19th Mar 20249:43 amRNSContract win
13th Mar 202410:49 amRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSTotal Voting Rights
26th Feb 20244:28 pmRNSBlock listing six monthly return
16th Feb 202412:38 pmRNSDirector/PDMR Shareholding
1st Feb 202410:02 amRNSTotal Voting Rights
29th Jan 20247:00 amRNSContract Win
17th Jan 20243:25 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSInterim Report 2023
2nd Jan 202412:05 pmRNSTotal Voting Rights
22nd Dec 202312:07 pmRNSHolding(s) in Company
13th Dec 20237:01 amRNSDirectorate Change
13th Dec 20237:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.